Today: 10 March 2026
Subscribe
Browse Category

Earnings Reports 15 January 2026 - 16 January 2026

Boston Scientific (BSX) stock drops after $14.5B Penumbra deal; FDA nod and earnings date ahead

Boston Scientific (BSX) stock drops after $14.5B Penumbra deal; FDA nod and earnings date ahead

Boston Scientific shares fell 4% Thursday after it announced a $14.5 billion cash-and-stock deal to buy Penumbra at $374 per share. Penumbra stock jumped 12% to $350.49. Boston Scientific warned of near-term EPS dilution and will fund about $11 billion in cash using debt and existing funds. Investors are watching for more details ahead of Boston Scientific’s earnings report on Feb. 4.
16 January 2026
···
Lam Research stock rises after hours as TSMC capex signal and analyst upgrades lift chip tools

Lam Research stock rises after hours as TSMC capex signal and analyst upgrades lift chip tools

Lam Research shares jumped 4.2% to $217.47 in after-hours trading Thursday, following broker upgrades and TSMC’s announcement of higher 2026 spending plans. Applied Materials, KLA, and U.S.-listed TSMC shares also posted strong gains. Wells Fargo, RBC Capital, Stifel, Morgan Stanley, and Barclays all raised price targets for Lam, citing robust demand in wafer-fab equipment and AI-related growth.
15 January 2026
·······
Dow Jones today: Index jumps nearly 300 points as Goldman earnings and TSMC outlook lift Wall Street

Dow Jones today: Index jumps nearly 300 points as Goldman earnings and TSMC outlook lift Wall Street

The Dow Jones closed up 292.81 points at 49,442.44 on Thursday, ending a two-day slide as strong bank earnings and Taiwan Semiconductor’s bullish outlook lifted sentiment. Goldman Sachs, Morgan Stanley, and BlackRock all beat profit forecasts. Chip stocks rebounded after Taiwan Semiconductor projected nearly 30% revenue growth for 2026. Weekly jobless claims fell to 198,000, signaling continued labor market stability.
15 January 2026
·····
Goldman Sachs stock jumps after earnings beat and dividend hike — here’s what moved GS

Goldman Sachs stock jumps after earnings beat and dividend hike — here’s what moved GS

Goldman Sachs shares rose 4.6% to $975.86 in after-hours trading Thursday after the bank posted quarterly earnings of $14.01 per share on $13.45 billion in revenue, beating estimates. The company raised its quarterly dividend to $4.50 per share. Net earnings reached $4.62 billion, with Global Banking & Markets contributing $10.41 billion in revenue. Operating costs increased due to higher compensation and transaction expenses.
15 January 2026
··
Morgan Stanley stock jumps nearly 6% after earnings beat as deal fees rebound

Morgan Stanley stock jumps nearly 6% after earnings beat as deal fees rebound

Morgan Stanley shares rose 5.8% to $191.23 in after-hours trading Thursday after fourth-quarter profit beat estimates. Investment banking revenue jumped 47% to $2.41 billion, boosted by a rebound in debt underwriting and deal activity. Executives cited a strong deal pipeline but warned of geopolitical and macroeconomic risks. Wealth management revenue climbed 13% to $8.43 billion.
15 January 2026
··
Dow, S&P 500 rebound as TSMC sparks chip rally and big-bank earnings lift Wall Street

Dow, S&P 500 rebound as TSMC sparks chip rally and big-bank earnings lift Wall Street

TSMC reported a 35% jump in quarterly profit and forecast 2026 revenue growth near 30%, lifting chip stocks and pushing the S&P 500 up 0.26%. Morgan Stanley and Goldman Sachs beat earnings estimates on strong investment banking and trading. Oil fell 4.6% to $59.19 after Trump’s comments eased supply fears. BlackRock’s assets under management hit a record $14 trillion.
15 January 2026
·······
Robinhood Stock Slides Ahead of Feb. 10 Earnings as a $230 “Double” Case Circulates

Robinhood Stock Slides Ahead of Feb. 10 Earnings as a $230 “Double” Case Circulates

Robinhood shares fell 7.4% to $110.83 in late New York trading Thursday as investors focused on the company’s upcoming earnings report, due Feb. 10 after the close. Analysts expect quarterly earnings near $0.58 per share, with revenue up 31.7% to $1.33 billion. The stock has surged 183% over the past year but dropped after the company raised its expense guidance last quarter.
15 January 2026
··
Freeport-McMoRan stock near $60 as copper AI demand and Indonesia risks collide ahead of earnings

Freeport-McMoRan stock near $60 as copper AI demand and Indonesia risks collide ahead of earnings

Freeport-McMoRan shares held at $60.34 Thursday, near a 52-week high, as copper prices topped $13,000 a ton after Rio Tinto struck a supply deal with Amazon. Indonesian military rescued 18 Freeport workers after armed rebels surrounded them at the Grasberg mine. Options traders expect a 6.6% swing around next week’s earnings report. Raymond James raised its target price to $66.
15 January 2026
··
IBM stock slides as Sovereign Core rollout sharpens focus on ‘digital sovereignty’ ahead of Jan. 28 earnings

IBM stock slides as Sovereign Core rollout sharpens focus on ‘digital sovereignty’ ahead of Jan. 28 earnings

IBM shares fell 2.7% to $300.56 in afternoon trading Thursday after a volatile session. The company launched “Sovereign Core,” new software aimed at enterprises and governments needing local control over cloud and AI workloads. A tech preview begins in February, with general release planned for mid-2026. Investors await IBM’s quarterly results on January 28 for further guidance.
15 January 2026
···
Coca-Cola stock dips today as Coke taps first chief digital officer ahead of earnings

Coca-Cola stock dips today as Coke taps first chief digital officer ahead of earnings

Coca-Cola shares fell about 1% Thursday after the company announced a leadership overhaul, including its first Chief Digital Officer and shifting commercial duties away from the CFO. The changes take effect March 31, as Henrique Braun prepares to succeed James Quincey as CEO. Investors await the Feb. 10 earnings report and Feb. 17 CAGNY presentation for more details on strategy. PepsiCo shares rose 0.6%.
15 January 2026
···
Merck stock slips as FDA fast-track delays grab attention ahead of Feb. 3 earnings

Merck stock slips as FDA fast-track delays grab attention ahead of Feb. 3 earnings

Merck shares fell 0.2% to $110.75 Thursday after the FDA delayed decisions in its new voucher fast-track program, according to Reuters. The FDA postponed reviews of drugs from Sanofi, Disc Medicine, and Eli Lilly, citing safety concerns. Investors are watching for Merck’s Feb. 3 earnings and updates on its drug pipeline. Healthcare stocks broadly declined, with Eli Lilly down 3.6%.
15 January 2026
···
1 … 108 109 110 111 112 … 227
Go toTop